Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wajd Alkabbani

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The American Journal of Gastroenterology|August 21, 2025
Letter to the EditorSara J Cromer, Wajd Alkabbani, Elisabetta Patorno
Neurology|February 15, 2023
Pioglitazone and Lower Risk of Dementia: Will This Change Practice?Colleen J Maxwell, Wajd Alkabbani, Sevil Yasar
Therapeutic Advances in Drug Safety|February 8, 2021
Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviewsRyan Pelletier, Kelvin Ng, Wajd Alkabbani, et al.
Endocrinology, Diabetes & Metabolism|July 25, 2020
The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviewsRyan Pelletier, Kelvin Ng, Wajd Alkabbani, et al.
Drug Safety|March 5, 2022
Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting DataWajd Alkabbani, Ryan Pelletier, Michael A Beazely, et al.
Diabetes, Obesity & Metabolism|August 11, 2023
Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United KingdomWajd Alkabbani, Baiju R Shah, Arsène Zongo, et al.
International Journal of Epidemiology|September 1, 2022
Hypoglycaemia and the risk of dementia: a population-based cohort study using exposure density samplingWajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, et al.
Diabetes, Obesity & Metabolism|November 28, 2023
Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunitiesWajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, et al.
Addiction (Abingdon, England)|June 27, 2019
Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort studyWajd Alkabbani, Ruth Ann Marrie, Shawn Bugden, et al.
Diabetes Care|December 14, 2022
Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort StudyWajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The American Journal of Gastroenterology|August 21, 2025
Letter to the EditorSara J Cromer, Wajd Alkabbani, Elisabetta Patorno
Neurology|February 15, 2023
Pioglitazone and Lower Risk of Dementia: Will This Change Practice?Colleen J Maxwell, Wajd Alkabbani, Sevil Yasar
Therapeutic Advances in Drug Safety|February 8, 2021
Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviewsRyan Pelletier, Kelvin Ng, Wajd Alkabbani, et al.
Endocrinology, Diabetes & Metabolism|July 25, 2020
The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviewsRyan Pelletier, Kelvin Ng, Wajd Alkabbani, et al.
Drug Safety|March 5, 2022
Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting DataWajd Alkabbani, Ryan Pelletier, Michael A Beazely, et al.
Diabetes, Obesity & Metabolism|August 11, 2023
Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United KingdomWajd Alkabbani, Baiju R Shah, Arsène Zongo, et al.
International Journal of Epidemiology|September 1, 2022
Hypoglycaemia and the risk of dementia: a population-based cohort study using exposure density samplingWajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, et al.
Diabetes, Obesity & Metabolism|November 28, 2023
Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunitiesWajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, et al.
Addiction (Abingdon, England)|June 27, 2019
Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort studyWajd Alkabbani, Ruth Ann Marrie, Shawn Bugden, et al.
Diabetes Care|December 14, 2022
Associations of Mid- and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort StudyWajd Alkabbani, Colleen J Maxwell, Ruth Ann Marrie, et al.
Pageof 4